US Patent 10493092 Antisense compounds
Patent 10493092 was granted and assigned to Ionis Pharmaceuticals on December, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10493092 Antisense compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
